53 related articles for article (PubMed ID: 1466020)
21. Expression of human insulin gene wrapped with chitosan nanoparticles in NIH3T3 cells and diabetic rats.
Niu L; Xu YC; Xie HY; Dai Z; Tang HQ
Acta Pharmacol Sin; 2008 Nov; 29(11):1342-9. PubMed ID: 18954529
[TBL] [Abstract][Full Text] [Related]
22. Daily exposure to inhomogeneous static magnetic field significantly reduces blood glucose level in diabetic mice.
László JF; Szilvási J; Fényi A; Szalai A; Gyires K; Pórszász R
Int J Radiat Biol; 2011 Jan; 87(1):36-45. PubMed ID: 20961270
[TBL] [Abstract][Full Text] [Related]
23. Intraperitoneally implanted artificial pancrease with transkaryotic beta-cells on microcarrier beads in a diffusion chamber improves hyperglycemia after 90% pancreatectomy in rats.
Sasaki S; Nio Y; Hirahara N; Sato Y; Inoue Y; Iguchi C; Yamasawa K; Tamura K
In Vivo; 2000; 14(4):535-41. PubMed ID: 10945170
[TBL] [Abstract][Full Text] [Related]
24. Adiponectin gene therapy of streptozotocin-induced diabetic mice using hydrodynamic injection.
Fukushima M; Hattori Y; Tsukada H; Koga K; Kajiwara E; Kawano K; Kobayashi T; Kamata K; Maitani Y
J Gene Med; 2007 Nov; 9(11):976-85. PubMed ID: 17868184
[TBL] [Abstract][Full Text] [Related]
25. Single subcutaneous administration of RGDK-lipopeptide:rhPDGF-B gene complex heals wounds in streptozotocin-induced diabetic rats.
Bhattacharyya J; Mondal G; Madhusudana K; Agawane SB; Ramakrishna S; Gangireddy SR; Madhavi RD; Reddy PK; Konda VR; Rao SR; Udaykumar P; Chaudhuri A
Mol Pharm; 2009; 6(3):918-27. PubMed ID: 19388683
[TBL] [Abstract][Full Text] [Related]
26. Directed overexpression of insulin in Leydig cells causes a progressive loss of germ cells.
Shirneshan K; Binder S; Böhm D; Wolf S; Sancken U; Meinhardt A; Schmid M; Engel W; Adham IM
Mol Cell Endocrinol; 2008 Nov; 295(1-2):79-86. PubMed ID: 18692115
[TBL] [Abstract][Full Text] [Related]
27. Allograft of microencapsulated islets in agarose gel in streptozotocin-induced and nonobese diabetic mice.
Iwata H; Takagi T; Yamashita K; Kobayashi K; Amemiya H
Transplant Proc; 1992 Jun; 24(3):997. PubMed ID: 1604705
[No Abstract] [Full Text] [Related]
28. Oral route of mini-proinsulin-expressing Ganoderma lucidum decreases blood glucose level in streptozocin-induced diabetic rats.
Ni T; Hu Y; Sun L; Chen X; Zhong J; Ma H; Lin Z
Int J Mol Med; 2007 Jul; 20(1):45-51. PubMed ID: 17549387
[TBL] [Abstract][Full Text] [Related]
29. [Cell therapy and gene therapy in diabetes mellitus].
Seufert J
MMW Fortschr Med; 2004 May; 146(20):39-40. PubMed ID: 15344732
[No Abstract] [Full Text] [Related]
30. Expression and secretion of human proinsulin-B10 from mouse salivary glands: implications for the treatment of type I diabetes mellitus.
Rowzee AM; Perez-Riveros PJ; Zheng C; Krygowski S; Baum BJ; Cawley NX
PLoS One; 2013; 8(3):e59222. PubMed ID: 23554999
[TBL] [Abstract][Full Text] [Related]
31. Reversal of diabetes in the rat by injection of hematopoietic stem cells infected with recombinant adeno-associated virus containing the preproinsulin II gene.
Bochan MR; Shah R; Sidner RA; Jindal RM
Transplant Proc; 1999; 31(1-2):690-1. PubMed ID: 10083298
[No Abstract] [Full Text] [Related]
32. Hepatic expression of the human insulin gene reduces glucose levels in vivo in diabetic mice model.
Ajamian F; Titok T; Suhorada E; Ruban T; Reeben M
Diabetes Metab; 2003 Sep; 29(4 Pt 1):424-9. PubMed ID: 14526271
[TBL] [Abstract][Full Text] [Related]
33. Reversal of hyperglycemia in diabetic NOD mice by human proinsulin gene therapy.
Kasten-Jolly J; Aubrey MT; Conti DJ; Rosano TG; Ross JS; Freed BM
Transplant Proc; 1997 Jun; 29(4):2216-8. PubMed ID: 9193599
[No Abstract] [Full Text] [Related]
34. Insulin delivery by somatic cell gene therapy.
Stewart C; Taylor NA; Docherty K; Bailey CJ
J Mol Endocrinol; 1993 Dec; 11(3):335-41. PubMed ID: 8148041
[TBL] [Abstract][Full Text] [Related]
35. Prospects for insulin delivery by ex-vivo somatic cell gene therapy.
Bailey CJ; Davies EL; Docherty K
J Mol Med (Berl); 1999 Jan; 77(1):244-9. PubMed ID: 9930972
[TBL] [Abstract][Full Text] [Related]
36. A study on the anti-diabetic activity of Coccinia indica in dogs.
Singh N; Singh SP; Vrat S; Misra N; Dixit KS; Kohli RP
Indian J Med Sci; 1985 Feb; 39(2):27-9, 42. PubMed ID: 3997215
[No Abstract] [Full Text] [Related]
37. Treatment of diabetic mice with encapsulated fibroblasts producing human proinsulin.
Taniguchi H; Nakauchi H; Iwata H; Amemiya H; Fukao K
Transplant Proc; 1992 Dec; 24(6):2977-8. PubMed ID: 1466020
[No Abstract] [Full Text] [Related]
38. Intramuscular injection of naked plasmid DNA encoding human preproinsulin gene in streptozotocin-diabetes mice results in a significant reduction of blood glucose level.
Wang LY; Sun W; Chen MZ; Wang X
Sheng Li Xue Bao; 2003 Dec; 55(6):641-7. PubMed ID: 14695479
[TBL] [Abstract][Full Text] [Related]
39. In vivo gene therapy of type I diabetic mellitus using a cationic emulsion containing an Epstein Barr Virus (EBV) based plasmid vector.
Yoo HS; Mazda O; Lee HY; Kim JC; Kwon SM; Lee JE; Kwon IC; Jeong H; Jeong YS; Jeong SY
J Control Release; 2006 May; 112(1):139-44. PubMed ID: 16530875
[TBL] [Abstract][Full Text] [Related]
40. Loss of ganciclovir sensitivity by exclusion of thymidine kinase gene from transplanted proinsulin-producing fibroblasts as a gene therapy model for diabetes.
Yoshimoto K; Murakami R; Moritani M; Ohta M; Iwahana H; Nakauchi H; Itakura M
Gene Ther; 1996 Mar; 3(3):230-4. PubMed ID: 8646554
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
